The future of real-world evidence
A focus on end-to-end, AI-driven, internally developed solutions
Biopharma is placing greater emphasis on real-world evidence (RWE), a Deloitte life-sciences survey finds. RWE helps leaders show value for access, understand the patient journey, and provide more data.
Measuring the return from pharmaceutical innovation 2016
Balancing the R&D equation
The seventh annual pharmaceutical innovation study, co-produced by the Deloitte Center for Health Solutions in the US and the UK, looks at the challenges the industry faces in generating returns from its R&D investments.